These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27049548)

  • 1. President's message. The perfect storm: Substance Abuse and Mental Health Services Administration (SAMHSA) Buprenorphine notice of proposed rule-making (NPRM).
    Morrone WR
    J Addict Dis; 2016; 35(2):157-8. PubMed ID: 27049548
    [No Abstract]   [Full Text] [Related]  

  • 2. SAMHSA outlines how to treat addiction to prescription painkillers and heroin in physicians' offices.
    Conn Med; 2003 Feb; 67(2):103-4. PubMed ID: 12664838
    [No Abstract]   [Full Text] [Related]  

  • 3. Agency offers guidance on office-based drug treatment for opioid addiction.
    Mitka M
    JAMA; 2003 Feb; 289(6):690. PubMed ID: 12585931
    [No Abstract]   [Full Text] [Related]  

  • 4. Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions.
    Spetz J; Toretsky C; Chapman S; Phoenix B; Tierney M
    JAMA; 2019 Apr; 321(14):1407-1408. PubMed ID: 30964519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use and abuse of opioids. President's message.
    Lande RG
    J Addict Dis; 2010 Oct; 29(4):502-3. PubMed ID: 20924888
    [No Abstract]   [Full Text] [Related]  

  • 6. Opioid drugs in maintenance and detoxification treatment of opiate addiction; proposed modification of dispensing restrictions for buprenorphine and buprenorphine combination as used in approved opioid treatment medications. Final rule.
    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services (HHS)
    Fed Regist; 2012 Dec; 77(235):72752-61. PubMed ID: 23227572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine for office-based treatment of patients with opioid addiction.
    Manlandro JJ
    J Am Osteopath Assoc; 2005 Jun; 105(6 Suppl 3):S8-13. PubMed ID: 16118361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid drugs in maintenance and detoxification treatment of opiate addiction; Substance Abuse and Mental Health Services Administration, HHS. Final rule.
    Fed Regist; 2001 Jan; 66(11):4076-102. PubMed ID: 11503765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. President's message.
    Kushner MD; Balsara S
    J Addict Dis; 2021; 39(4):433-435. PubMed ID: 34669552
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
    Tofighi B; Grossman E; Goldfeld KS; Williams AR; Rotrosen J; Lee JD
    Subst Use Misuse; 2015; 50(12):1571-8. PubMed ID: 26623697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.
    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services
    Fed Regist; 2003 May; 68(99):27937-9. PubMed ID: 12762334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient opioid addiction treatment using buprenorphine.
    Roberson CM
    Ala Nurse; 2010; 37(2):13-6; quiz 17. PubMed ID: 20666206
    [No Abstract]   [Full Text] [Related]  

  • 13. Fiscal year (FY) 1998 funding opportunities--SAMHSA. Notice of funding availability.
    Fed Regist; 1998 Apr; 63(77):19928-32. PubMed ID: 10179317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options for opiate addiction.
    J Ky Med Assoc; 2004 May; 102(5):221-4. PubMed ID: 15152448
    [No Abstract]   [Full Text] [Related]  

  • 15. Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors.
    Oliva EM; Harris AH; Trafton JA; Gordon AJ
    Drug Alcohol Depend; 2012 May; 122(3):241-6. PubMed ID: 22115887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grant award to the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska. Center for Substance Abuse Treatment (CSAT), Center for Mental Health Services (CMHS), Substance Abuse and Mental Health Services Administration (SAMHSA), HHS. Availability of grant funds for the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska.
    Fed Regist; 1999 Apr; 64(73):18922-3. PubMed ID: 10558551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From the Alcohol, Drug Abuse, and Mental Health Administration.
    Goodwin FK
    JAMA; 1990 May 23-30; 263(20):2725. PubMed ID: 2159077
    [No Abstract]   [Full Text] [Related]  

  • 18. Public policy statement on buprenorphine for opiate dependence and withdrawal.
    J Addict Dis; 2004; 23(4):116-7. PubMed ID: 15534969
    [No Abstract]   [Full Text] [Related]  

  • 19. A new era in opioid dependency treatment. Recent law allows qualified physicians to provide care in office setting.
    Clark HW
    Postgrad Med; 2001 Jun; 109(6):15-6, 25. PubMed ID: 11424343
    [No Abstract]   [Full Text] [Related]  

  • 20. Fiscal year (FY) 1999 funding opportunities. Substance Abuse and Mental Health Services Administration, HHS. Notice of funding availability.
    Fed Regist; 1999 Mar; 64(44):11027-31. PubMed ID: 10557624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.